Organizational AI adoption has dramatically increased over the years largely due to generative AI, leaving organizations to navigate challenges while rapidly scaling and adopting new technologies. In this episode, Jen is joined by Vynamic’s Chris Wuenschel & Frank Longo, as well as AI Mobilization Offering Lead, Todd Quartiere, to discuss their experiences with different factors that can make or break AI transformation programs.

To learn more about implementing AI within your organization, check out the AI At Vynamic page on Vynamic’s website for more information.

Podcast Tags: health, healthcare, healthcare news, generative AI, innovation, responsible use, ChatGPT, tech transformation, digital transformation, life sciences

Source Links:

• The state of AI in early 2024: Gen AI adoption spikes and starts to generate value

Panel – Jen Burke, Todd Quartiere, Chris Wuenschel, Frank Longo

Research & Production – Everly Petruzzelli

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In today’s competitive and dynamic pharmaceutical landscape, mastering the art of brand planning and management is crucial to success. In this episode, Jen and Mindy are joined by Vynamic’s Brand Strategy Offering Lead, Liza Flaherty, to discuss common challenges, best practices, and latest trends impacting the process of creating an effective brand plan.

For our listeners, if you want to learn more about Vynamic’s Brand Strategy offering and brand planning capabilities, please email Liza.Flaherty@vynamic.com or visit our website for more information.

Podcast Tags: healthcare, life sciences, product launch, brand planning, life sciences trends

Source Links:

• The Essential Guide to Creating and Implementing a Successful Pharmaceutical Brand Plan
• Navigating the Inflation Reduction Act’s Impact on Drug Pricing and Innovation
• The Inflation Reduction Act: the Undoing of Pharma Marketing or a Catalyst for Innovation?.
• Go-to-Market Strategy for Pharmaceuticals
• Reimagining the Brand Planning Process in Healthcare

Panel – Jen Burke, Mindy McGrath, Liza Flaherty

Research & Production – Liza Flaherty, Adrea Cope & Everly Petruzzelli

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Two years after the announcement that Veeva and Salesforce would part ways, Life Sciences organizations are racing to evaluate their options and select their CRM partner before the 2025 cutover. Jen is joined by Vynamic’s Life Sciences Commercial Operations Lead, Jeremy Shirey, and Tech & Digital Transformation Service Lead, Vince Annerhed-Harris as well as special guests, CodeScience’s CEO, Mike Utell, and Chief Revenue Officer, Sean Hogan, to discuss how Life Sciences leaders should approach this decision and transition to minimize disruption and maximize business value.

For more information about CodeScience, visit their website:

For more information about Vynamic’s work in Commercial Operations and Tech & Digital Transformation, visit:

Podcast Tags: healthcare, life sciences, healthcare technology, healthcare news, Veeva, Salesforce, tech and digital transformation, CRM, commercial operations, CodeScience

Panel – Jen Burke, Jeremy Shirey, Vince Annerhed-Harris, Mike Utell, Sean Hogan

Research & Production – Jen Burke, Jeremy Shirey, Vince Annerhed-Harris

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including the Supreme Court’s overturning of Chevron Deference and what this will mean for the health industry, as well as strategic shifts made by Walgreens under their new CEO, and the ongoing impact of Microsoft’s global IT outage on health systems, hospitals, and clinics.

Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, Supreme Court, Chevron Deference, Walgreens, pharma, pharmacy, CrowdStrike, Microsoft, IT outage

Source Links:

• Health Care Impacts Following Chevron Decision
• Supreme Court overrules Chevron deference, dealing blow to federal healthcare agencies
• After Billions in Losses, Walgreens Doesn’t Want to Own VillageMD
• Walgreens slashes profit guidance with plans to close more pharmacy stores, cut stake in VillageMD
• Impacts from global IT outage

Panel – Jen Burke, Mindy McGrath, Ryan Hummel

Research & Production – Anna Briccetti, Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

One of the advantages of serving clients across multiple geographies is that Vynamic can see firsthand how the differences in health systems play out in terms of spend, outcomes, and innovation. Jen & Ryan are joined by Vynamic London’s Oliver White to discuss key differences between the health systems in each country and what they can learn from one another as they move healthcare delivery out of the hospital and into the community setting. In one sense, the US and UK represent two extremes on the delivery system spectrum: the US has the largest private sector system globally while the UK has the largest publicly funded system. They also differ in key metrics around healthcare spend and outcomes (01:19), science and technology (04:21), and wait times for elective procedures and emergency care (06:21). Despite these differences, both systems are focused on improving cost and customer satisfaction – especially when it comes to telehealth and home care (09:05). One model the NHS has put forward in this effort is Community Crisis Response Teams (12:38) – a model that could be attractive as US health systems look to transition care to the home and alleviate emergency department (ED) volumes (15:13). While implementing such a model could present scaling challenges in the US market (16:45), it could also offer opportunities for health plans and providers to improve quality, outcomes, and patient satisfaction (18:29).

Podcast Tags: healthcare, providers, health plans, public health, NHS, CMS, telehealth, crisis care

Source Links:

· https://www.usnews.com/news/healthiest-communities/articles/2019-12-11/survey-finds-fragmented-us-health-care-impedes-coordination-among-providers

· https://www.commonwealthfund.org/international-health-policy-center/countries/england

· https://www.commonwealthfund.org/international-health-policy-center/countries/united-states

· https://www.commonwealthfund.org/blog/2018/what-can-us-and-england-learn-each-others-health-care-reforms

· https://www.healthcareadministration.com/brief-comparison-uk-healthcare-system-vs-u-s-healthcare-system/#:~:text=While%20both%20systems%20have%20world,tax%20based%20system%20versus%20the

· https://www.england.nhs.uk/community-health-services/urgent-community-response-services/

· https://www.england.nhs.uk/wp-content/uploads/2020/11/B0252-Urgent-community-response-2-hour-and-2-days-standards-guidance-30-November-2020.pdf

· https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465904/

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Oliver White, Director

Oliver.white@vynamic.com

Ryan Hummel, Executive and Head of Provider Sector

ryan.hummel@vynamic.com

Jen Burke, Director and Healthcare Industry Strategist

jen.burke@vynamic.com

The FemTech sector has seen major growth in the last 5 years – and as the healthcare industry increases its focus on equity, is only projected to keep growing. In this Women’s History Month episode, Jen is joined by Vynamic’s Diana Kuritza, Jen Proietti-Fox and HelloGina’s Daphne Petrich to discuss the latest trends in FemTech and what it could mean for women’s health going forward.

Podcast Tags: healthcare, health tech, women’s health, women’s history month, health equity, digital health

Source Links:

· Make 2023 the year of prioritizing women’s health

· 2023 PREDICTIONS—THE GOOD, THE BAD, AND THE UGLY

· European FemTech trends and startups to watch in 2023 | With insights from Essity Ventures

· What To Expect for Femtech in 2023?

· Despite 2022’s headwinds, women’s health startups did better than ever before

· The dawn of the FemTech revolution

· How FemTech is tackling the female health gap

· Femtech’s Limited Role in Tackling Healthcare Inequity

For more information on HelloGina please visit, https://www.helloginahealth.com/

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at

1-888-VYNAMIC.

Daphne Petrich, US Business Development Lead at HelloBetter

d.petrich@hellobetter.de

Jen Proietti-Fox, Director

Jen.proietti-fox@vynamic.com

Diana Kuritza, Manager

Diana.kuritza@vynamic.com

Jen Burke, Healthcare Industry Strategist

Jen.Burke@vynamic.com

The re-emergence of clinical research into psychedelics as mental health treatment has become a promising development – particularly in light of the current global mental health crisis. However, persistent stigma around psychedelics, regulatory hurdles, and research challenges are a few factors to overcome before psychedelics could be more widely available. In today’s episode, Jen is joined by Vynamic’s Nick Fletcher and Grace Burtonwood to shine light on the opportunities and challenges psychedelics present to the mental health market.

Podcast Tags: healthcare, life sciences, healthcare news, mental health, psychedelics

Source Links:

• WHO Topics: Mental Health
• WHO Fact Sheets: Mental Disorders
• WHO: Global Health Estimates
• Multidisciplinary Association for Psychedelic Studies (MAPS)
• National Institute on Drug Abuse (NIDA)
• Compass Pathways
• BBC – FDA Advisory Committee Vote on MDMA
• FDA Guidance on Clinical Trials with Psychedelic Drugs
• How To Change Your Mind (Michael Pollen)
• European Medicines Agency (EMA)

Panel – Grace Burtonwood, Jen Burke, Nick Fletcher

Research & Production – Everly Petruzzelli, Nick Fletcher

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jen, Karan, and Ollie discuss recent newsworthy items, including the political shifts taking place across Europe and their potential impact to the pharma sector, as well as the challenges posed by medicine stockpiling and breakthroughs in hemophilia treatment.

Podcast Tags: healthcare, healthcare news, public health, Labour, pharma, medicine stockpiling, haemophilia, NHS, Novo Nordisk

Source Links:

• With Europe facing right turn, how will public health be affected?
• Pharma responds to 2024 UK General Election
• Romanian hard-right takes healthcare on the road ahead of EU polls
• EU elections: a moment for pan-European health
• New Labour government backs pharma reform in UK
• Massive stockpiling of medicines increases patient risks, warns EU coalition
• Czechia slams Germany over drug stockpiling
• EU plan for medicine stockpile could worsen UK’s record shortages
• Six EU countries push to end mandatory stockpiling of medicines
• Haemophilia gene therapy now available to NHS patients
• Novo Nordisk shares positive results for Mim8 in late-stage haemophilia A trial
• England, Denmark back CSL’s haemophilia B gene therapy
• I have £2.6m blood and it has \’cured\’ my haemophilia

Panel – Jen Burke, Karan Pandya, Ollie May

Research & Production – Karan Pandya

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.